At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Cellular Origins has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform ...

LOTTE will manufacture antibody drug substance for Ottimo Pharma’s product at LOTTE’s Syracuse Bio Campus in New York.

How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

Lotte Biologics signed a contract manufacturing agreement with U.K.-based biotech company Ottimo Pharma for its production of ...

Piramal Pharma’s future is anchored in scaling its CDMO business to $1.2 billion, expanding complex hospital generics, and ...

Solvents are also under scrutiny for their environmental and safety impact. With stricter regulatory controls on toxicity and ...

LOTTE BIOLOGICS has signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma, a biopharmaceutical company developing first-in-class, PD1/VEGFR2 dual pathway antibodies to ...